Do you find our website user friendly?
Yes   No

Information on Xeomin, A New Botox

Xeomin (incobotulinum Toxin A) is the newest of the Botox like drugs to become FDA approved. Xeomin is manufactured by Merz pharmaceuticals and is the third botulinum toxin available in the US to treat cervical dystonia, blepharospasm, and glabeller lines. It joins Botox (onabotulinum toxin A, Allergan) and Dysport (abobotulinum toxin A, Medicis). These neurotoxins also have many “off-label” uses including migraine treatment, forehead lines, “crows feet” as well as for decreasing sweating. Xeomin is marketed as a “purer” botulinum toxin and seems to have a faster onset of action than Botox. It is also supplied similarly to Botox, available in both 50 and 100 unit vials.

 

You Might Also Enjoy...

Telehealth: The Advantages of Telemedicine

Struggles to get to the clinic? Trying to reduce your exposure to COVID-19, as well as other contagious illnesses, and still need to see your doctor? Telehealth is safe and easy — receive quality care from anywhere.

American Academy of Ophthalmology Coronavirus Update

The AAO recently published information suggesting symptoms of conjunctivitis, including red and watery eyes, may be signs of novel coronavirus infection. It is imperative that everyone practice good hand, face, and eye hygiene to prevent dissemination.

First to Introduce to South Florida the KAMRA® Corneal Inlay

Cohen Laser & Vision Center is Proud to Be the First to Introduce to South Florida the KAMRA® Corneal Inlay, a Solution to Eliminate Your Dependence on Reading Glasses December 06, 2017 10:05 AM Eastern Standard Time BOCA RATON, Fla.–(BUSINESS WIRE)–Presb

7 Commonly Asked Lasik Eye Surgery Questions

1. Does Lasik hurt? Dr. Cohen takes every effort to make sure his patients are completely comfortable before the Lasik surgery begins.  Patients are given a sedative and then topical numbing drops are applied to the eye.  Some patients report feeling a li

Twenty Questions Interview with Dr. Richard Cohen

Name and Title: G. Richard Cohen, M.D., Medical Director, Board Certified Ophthalmologist, Cornea and LASIK Specialist. Quote from Transactions of the American Ophthalmologic Society: “Photorefractive keratectomy can be safely performed in children with